FRAU, LUCIA
 Distribuzione geografica
Continente #
EU - Europa 396
NA - Nord America 351
AS - Asia 33
AF - Africa 5
SA - Sud America 4
Totale 789
Nazione #
IT - Italia 378
US - Stati Uniti d'America 347
CN - Cina 13
VN - Vietnam 9
FI - Finlandia 6
CA - Canada 4
CL - Cile 4
KR - Corea 4
RU - Federazione Russa 4
ZA - Sudafrica 4
CZ - Repubblica Ceca 2
IN - India 2
JP - Giappone 2
AE - Emirati Arabi Uniti 1
CG - Congo 1
DE - Germania 1
GB - Regno Unito 1
GR - Grecia 1
IE - Irlanda 1
IL - Israele 1
NL - Olanda 1
PK - Pakistan 1
SE - Svezia 1
Totale 789
Città #
Cagliari 361
Fairfield 38
Santa Cruz 34
Ashburn 28
Buffalo 25
Woodbridge 25
Houston 20
Seattle 19
Cambridge 17
Ann Arbor 11
Wilmington 10
Dong Ket 9
Las Vegas 8
Chicago 5
Helsinki 5
Los Angeles 5
Mountain View 5
Boardman 4
Clearwater 4
Shanghai 4
Wuhan 4
Columbus 3
Phoenix 3
Saint Petersburg 3
University Park 3
Bastia umbra 2
Brooklyn 2
Council Bluffs 2
Dallas 2
Hangzhou 2
Henderson 2
Muizenberg 2
Ottawa 2
Portland 2
Provo 2
Riva 2
Silverton 2
Athens 1
Austin 1
Beijing 1
Berkeley 1
Brazzaville 1
Büdelsdorf 1
Capoterra 1
Contursi 1
Dublin 1
Forlì 1
Genova 1
Herndon 1
Hiroshima 1
Iglesias 1
Johnson City 1
Lahore 1
Lincolnshire 1
Messina 1
Milan 1
Milpitas 1
Modi‘in Makkabbim Re‘ut 1
New Delhi 1
New York 1
Palo Alto 1
Potenza 1
Québec 1
Rome 1
San Diego 1
San Jose 1
Sant'antioco 1
Scranton 1
Toronto 1
Tsukuba 1
Totale 710
Nome #
Direct and long-lasting effects elicited by repeated drug administration on 50-kHz ultrasonic vocalizations are regulated differently: Implications for the study of the affective properties of drugs of abuse, file e2f56ed3-f998-3eaf-e053-3a05fe0a5d97 232
Role of movement in long-term basal ganglia changes: implications for abnormal motor responses, file e2f56ed3-b30c-3eaf-e053-3a05fe0a5d97 200
Novel (Hetero)arylalkenyl propargylamine compounds are protective in toxin-induced models of Parkinson's disease, file e2f56ed5-36af-3eaf-e053-3a05fe0a5d97 171
Late-onset Parkinsonism in NFκB/c-Rel-deficient mice, file e2f56ed3-9fd0-3eaf-e053-3a05fe0a5d97 157
Neuroprotective and anti-inflammatory effects of the adenosine A(2A) receptor antagonist ST1535 in a MPTP mouse model of Parkinson's disease., file e2f56ed3-ab9d-3eaf-e053-3a05fe0a5d97 4
Performance of movement in hemiparkinsonian rats influences the modifications induced by dopamine agonists in striatal efferent dynorphinergic neurons, file e2f56ed4-5465-3eaf-e053-3a05fe0a5d97 4
MPTP-induced dopamine neuron degeneration and glia activation is potentiated in MDMA pretreated mice, file e2f56ed4-5550-3eaf-e053-3a05fe0a5d97 4
Protective Agents in Parkinson's Disease: Caffeine and Adenosine A2A Receptor Antagonists, file e2f56ed4-58f3-3eaf-e053-3a05fe0a5d97 4
Microglial and astroglial activation by 3,4-methylenedioxymethamphetamine (MDMA) in mice depends on S(+) enantiomer and is associated with an increase in body temperature and motility, file e2f56ed4-5bac-3eaf-e053-3a05fe0a5d97 4
Alteration in the progression of dopamine neuron degeneration: May caffeine offer new perspective?, file e2f56ed4-5472-3eaf-e053-3a05fe0a5d97 3
Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6-OHDA lesioned rat, file e2f56ed4-5a57-3eaf-e053-3a05fe0a5d97 3
Effect of crowding, temperature and age on glia activation and dopaminergic neurotoxicity induced by MDMA in the mouse brain, file e2f56ed5-31a8-3eaf-e053-3a05fe0a5d97 3
Protective Agents in Parkinson’s Disease: Caffeine and Adenosine A2A Receptor Antagonists, file e2f56eda-8245-3eaf-e053-3a05fe0a5d97 3
Rosiglitazone decreases peroxisome proliferator receptor-gamma levels in microglia and inhibits TNF-alpha production: new evidences on neuroprotection in a progressive Parkinson's disease model. , file e2f56ed3-bd99-3eaf-e053-3a05fe0a5d97 2
Antagonism of Adenosine A1 or A2A Receptors Amplifies the Effects of 3,4-Methylendioxymethamphetamine (MDMA) on Glial Activation in the Mouse Brain: Relevance to Caffeine-MDMA Interactions, file e2f56ed4-5876-3eaf-e053-3a05fe0a5d97 2
Contribution of Caffeine to the Psychostimulant, Neuroinflammatory and Neurotoxic Effects of Amphetamine-Related Drugs, file e2f56ed4-58fa-3eaf-e053-3a05fe0a5d97 2
Characterization of the antiparkinsonian effects of the new adenosine A2A receptor antagonist ST1535: acute and subchronic studies in rats, file e2f56ed4-5ac2-3eaf-e053-3a05fe0a5d97 2
Symptomatic and Neuroprotective Effects of A2A Receptor Antagonists in Parkinson’s Disease, file e2f56ed4-64e6-3eaf-e053-3a05fe0a5d97 2
Widespread reduction of dopamine cell bodies and terminals in adult rats exposed to a low dose regimen of MDMA during adolescence, file e2f56ed6-dcfd-3eaf-e053-3a05fe0a5d97 2
Caffeine Enhances Astroglia and Microglia Reactivity Induced by 3,4-Methylenedioxymethamphetamine (‘Ecstasy’) in Mouse Brain, file e2f56ed3-df18-3eaf-e053-3a05fe0a5d97 1
Influence of caffeine on 3,4-methylenedioxymethamphetamine-induced dopaminergic neuron degeneration and neuroinflammation is age-dependent, file e2f56ed8-1ee0-3eaf-e053-3a05fe0a5d97 1
Totale 806
Categoria #
all - tutte 1.487
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.487


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201942 0 0 0 0 0 0 0 0 0 0 19 23
2019/2020103 15 7 6 12 10 7 11 8 11 7 6 3
2020/202167 5 4 5 5 5 9 2 6 2 7 4 13
2021/2022106 7 10 6 2 9 8 8 3 4 6 34 9
2022/202376 5 4 29 15 5 2 4 3 1 2 6 0
2023/202427 4 1 2 1 2 3 1 0 1 8 4 0
Totale 806